Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 3200 of 3546 entries
View as:

ADVAIR® DISKUS® Inhaler (Fluticasone Propionate/Salmeterol) Versus SEREVENT® DISKUS® Inhaler (Salmeterol) For The Treatment Of Chronic Obstructive Pulmonary Disease Exacerbations. ADVAIR® DISKUS® Inhaler and SEREVENT® DISKUS® Inhaler Are Trademarks of the GSK Group of Companies.

Phase: N/A Priority: Normal
NCT ID: NCT00144911 Org: User:
Start: 10/31/04 End: 12/31/06 Due: 12/31/07

Immunogenicity & Reactogenicity of Boostrix 10 Years After Previous Booster Vaccination in Study NCT01267058

Phase: N/A Priority: Normal
NCT ID: NCT00548171 Org: User:
Start: 11/05/07 End: 04/30/08 Due: 04/30/09

Study of Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline's (GSK)Respiratory Syncytial Virus (RSV)Maternal Unadjuvanted Vaccine in Healthy Pregnant Women (Aged 18 to 40 Years) and Their Infants

Phase: N/A Priority: Normal
NCT ID: NCT04126213 Org: User:
Start: 11/05/19 End: 05/14/21 Due: 05/14/22

Impact of Migraine on Work Productivity in Patients Treated With a Combination Product Containing Sumatriptan and Naproxen Sodium or Triptan Monotherapy

Phase: N/A Priority: Normal
NCT ID: NCT01381497 Org: User:
Start: 03/31/10 End: 10/31/11 Due: 10/31/12

A Study to Investigate the Antimicrobial Activity of 2 Test Toothpastes

Phase: N/A Priority: Normal
NCT ID: NCT02856880 Org: User:
Start: 11/09/15 End: 12/11/15 Due: 12/11/16

Study Comparing the Immune Response of Fluarix and Fluzone Influenza Vaccines

Phase: N/A Priority: Normal
NCT ID: NCT00197288 Org: User:
Start: 10/31/05 End: 06/30/06 Due: 06/30/07

A First Time in Human Study in Healthy Volunteers to Investigate a New Medicine to Treat Malaria

Phase: N/A Priority: Normal
NCT ID: NCT00811356 Org: User:
Start: 12/11/08 End: 03/30/09 Due: 03/30/10

A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GSK Biologicals' Staphylococcal Investigational Vaccine in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT01160172 Org: User:
Start: 07/19/10 End: 08/23/12 Due: 08/23/13

The Prevalence of Osteoporotic Vertebral Compression Fractures (OVCF) in Korean Post Menopausal Women

Phase: N/A Priority: Normal
NCT ID: NCT01381588 Org: User:
Start: 10/31/10 End: 02/28/11 Due: 02/28/12

A Comparison of Ropinirole Immediate Release With Ropinirole Prolonged Release in Patients With Advanced Parkinson's

Phase: N/A Priority: Normal
NCT ID: NCT00331149 Org: User:
Start: 06/20/06 End: 08/29/07 Due: 08/29/08

Study of Two Doses of GSK Biologicals' Live Attenuated HRV Vaccine (Two Different Formulations) in Healthy Infants.

Phase: N/A Priority: Normal
NCT ID: NCT00729001 Org: User:
Start: 11/30/00 End: 09/30/02 Due: 09/30/03

Analysis of the Incidence of Expression of Tumor Antigens in Pathologically Proven Stage I, II and III Non-Small Cell Lung Cancer(NSCLC) in Asiatic Patients

Phase: N/A Priority: Normal
NCT ID: NCT01837511 Org: User:
Start: 08/31/07 End: 01/31/08 Due: 01/31/09

Outcomes in Patients Taking Fluticasone Propionate/Salmeterol Combination or Other Inhaled Corticosteroids

Phase: N/A Priority: Normal
NCT ID: NCT01332344 Org: User:
Start: 06/30/09 End: 06/30/10 Due: 06/30/11

Warming Sensation and Tolerability Study of Acetylcysteine 2% Oral Solution for Productive Cough

Phase: N/A Priority: Normal
NCT ID: NCT02822287 Org: User:
Start: 02/29/16 End: 03/31/16 Due: 03/31/17

Chemokine Coreceptor 5 (CCR5) Antagonist GW873140 In R5-Tropic Treatment-Experienced HIV-Infected Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00297076 Org: User:
Start: 07/31/05 End: 10/31/07 Due: 10/31/08

A Study to Evaluate the Effect of GW870086X on Allergen Challenge in Mild Asthmatics

Phase: N/A Priority: Normal
NCT ID: NCT00857857 Org: User:
Start: 02/16/09 End: 11/03/09 Due: 11/03/10

Study to Evaluate Immunogenicity of the Hepatitis B Antigen of the GSK Biologicals' Candidate Malaria Vaccine (257049)

Phase: N/A Priority: Normal
NCT ID: NCT01345240 Org: User:
Start: 11/17/11 End: 02/09/17 Due: 02/09/18

Comparison of IV Topotecan/Docetaxel to Docetaxel Alone in Second-Line Stage IIIB/IV Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00065182 Org: User:
Start: 08/14/03 End: 08/30/07 Due: 08/30/08

This Study Will Investigate the Effect of Single Oral Doses of Retosiban on Cardiac Repolarization, With Moxifloxacin as a Positive Control in Healthy Volunteers.

Phase: N/A Priority: Normal
NCT ID: NCT01702376 Org: User:
Start: 10/03/12 End: 01/14/13 Due: 01/14/14

Immunogenicity and Reactogenicity of MPL Adjuvanted Recombinant Hepatitis B- Vaccine and Engerix™-B in Adult Non-Responders

Phase: N/A Priority: Normal
NCT ID: NCT00697931 Org: User:
Start: 05/31/97 End: 06/30/98 Due: 06/30/99

Study to Assess the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine in Adults Aged 18 Years and Older With Blood Cancers

Phase: N/A Priority: Normal
NCT ID: NCT01767467 Org: User:
Start: 03/01/13 End: 01/06/17 Due: 01/06/18

Immunogenicity & Safety Study of GSK Biologicals' 208136 Vaccine Formulated With New Measles and Rubella Working Seeds

Phase: N/A Priority: Normal
NCT ID: NCT00892775 Org: User:
Start: 06/03/09 End: 12/13/10 Due: 12/13/11

GSK BHR Study (Sont - Second Study)

Phase: N/A Priority: Normal
NCT ID: NCT01324362 Org: User:
Start: 01/31/03 End: 10/31/04 Due: 10/31/05

A Study to Investigate the Efficacy and Safety With Gepotidacin in Japanese Female Participants With Uncomplicated Urinary Tract Infection (Acute Cystitis)

Phase: N/A Priority: Normal
NCT ID: NCT05630833 Org: User:
Start: 01/11/23 End: 02/02/24 Due: 02/02/25

Local Skin Safety Study of a Topical Pain Relief Spray Containing a Combination of Diclofenac, Methyl Salicylate, and Menthol

Phase: N/A Priority: Normal
NCT ID: NCT02400320 Org: User:
Start: 03/01/16 End: 06/30/16 Due: 06/30/17